Holen Sie sich die Stockscreener-App
1.31
2.96%
-0.04
Vorhandelsmarkt:
1.30
-0.01
-0.76%
Schlusskurs vom Vortag:
$1.35
Offen:
$1.35
24-Stunden-Volumen:
68,422
Relative Volume:
0.04
Marktkapitalisierung:
$11.76M
Einnahmen:
$5.64M
Nettoeinkommen (Verlust:
$-23.88M
KGV:
-2.4717
EPS:
-0.53
Netto-Cashflow:
$-22.36M
1W Leistung:
-0.76%
1M Leistung:
-3.68%
6M Leistung:
-21.08%
1J Leistung:
-72.93%
1-Tages-Spanne:
$1.28
$1.35
1-Wochen-Bereich:
$1.28
$1.36
52-Wochen-Spanne:
$0.95
$5.695
Evogene Ltd Stock (EVGN) Company Profile
Vergleichen Sie EVGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVGN
Evogene Ltd
|
1.31 | 11.76M | 5.64M | -23.88M | -22.36M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-07-29 | Eingeleitet | Aegis Capital | Buy |
| 2020-12-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2013-12-16 | Eingeleitet | Oppenheimer | Outperform |
Evogene Ltd Aktie (EVGN) Neueste Nachrichten
How many analysts rate Evogene Ltd. as a “Buy”Invest smarter with actionable stock recommendations - jammulinksnews.com
What markets is Evogene Ltd. expanding into Is SBCF stock a good long term investment optionMaximize returns with smart investment plans - jammulinksnews.com
Should I hold or sell Evogene Ltd. stock in 2025Explosive market performance - jammulinksnews.com
Why is Evogene Ltd. stock attracting strong analyst attentionPhenomenal capital gains - jammulinksnews.com
How does Evogene Ltd. compare to its industry peersCapitalize on market opportunities with confidence - jammulinksnews.com
Does Evogene Ltd. stock perform well during market downturnsCapitalize on market trends with confidence - jammulinksnews.com
What markets is EYEN expanding into Is Evogene Ltd. stock a good long term investment option - jammulinksnews.com
Is Evogene Ltd. stock overvalued or undervaluedOutstanding yields - jammulinksnews.com
What risks could impact Evogene Ltd. stock performanceRisk Managed Trading Strategy - Metal.it
Why Evogene Ltd. stock attracts strong analyst attentionFree Predictions - Metal.it
Is Evogene Ltd. a good long term investmentRemarkable growth - PrintWeekIndia
Evogene Ltd. Stock Analysis and ForecastExplosive earning power - PrintWeekIndia
How Evogene Ltd. stock reacts to Fed policy changesRecord-setting profit potential - jammulinksnews.com
What drives Evogene Ltd. stock priceExceptional trading results - PrintWeekIndia
What analysts say about Evogene Ltd. stockRemarkably fast returns - jammulinksnews.com
Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting - global-agriculture.com
How Evogene Ltd. stock compares to its top competitorsIs SBCF stock undervalued or overvalued nowFree Daily Stock Market Updates - Newser
Evogene Updates Proxy Card for August 2025 Shareholder Meeting - TipRanks
What makes Evogene Ltd. stock price move sharplyHigh Return Potential - Newser
How Evogene Ltd. stock performs during market volatilityChart Based Entries - Newser
Biomica Announces Closing of $20 Million Financing Round led by Shanghai Healthcare Capital - global-agriculture.com
AgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive Officer - global-agriculture.com
Finanzdaten der Evogene Ltd-Aktie (EVGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.97%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):